J2354
HCPCSOctreotide inj, non-depot
Official HCPCS Level II long descriptor
Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg
HCPCS Level II code J2354 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Octreotide inj, non-depot
Added to HCPCS: 2004-01-01
Nearby codes in J2
- J2323Natalizumab injection
- J2325Nesiritide injection
- J2326Inj, nusinersen, 0.1mg
- J2327Inj risankizumab-rzaa 1 mg
- J2329Inj ublituximab-xiiy, 1 mg
- J2350Injection, ocrelizumab, 1 mg
- J2351Inj ocrelizumab 1mg hya-ocsq
- J2353Octreotide injection, depot
- J2355Oprelvekin injection
- J2356Inj tezepelumab-ekko, 1mg
- J2357Omalizumab injection
- J2358Olanzapine long-acting inj
- J2359Inj. olanzapine, 0.5mg
- J2360Orphenadrine injection
- J2361Inj depemokimab-ulaa 1 mg
- J2371Inj phenylephrine hcl 20 mcg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.